{"id":961,"date":"2021-08-06T07:00:00","date_gmt":"2021-08-06T07:00:00","guid":{"rendered":"http:\/\/CBMijQFodHRwczovL3d3dy5tYXJpanVhbmFtb21lbnQubmV0L2ZlZGVyYWwtc2NpZW5jZS1hZ2VuY3ktaXNzdWVzLWZpcnN0LXJlcG9ydC1vbi10aGMtYW5kLWNiZC12YXJpYWJpbGl0eS1pbi1jYW5uYWJpcy1sYWJvcmF0b3J5LXRlc3RpbmctcmVzdWx0cy_SAQA"},"modified":"2021-08-06T07:00:00","modified_gmt":"2021-08-06T07:00:00","slug":"federal-science-agency-issues-first-report-on-thc-and-cbd-variability-in-cannabis-laboratory-testing-results-marijuana-moment","status":"publish","type":"post","link":"https:\/\/thcinct.com\/?p=961","title":{"rendered":"Federal Science Agency Issues First Report On THC And CBD Variability In Cannabis Laboratory Testing Results &#8211; Marijuana Moment"},"content":{"rendered":"<p>A federal science agency has released a new report as part of its effort to ensure that cannabis products are accurately tested and labeled for THC, CBD and more than a dozen other cannabinoids. It\u2019s part of an ongoing effort by the National Institute of Standards and Technology (NIST) to encourage standardized analysis of a wide range of cannabis compounds and contaminants across an ever-expanding class of legal products.<\/p>\n<p>The agency, part of the U.S. Department of Commerce, <a href=\"https:\/\/www.marijuanamoment.net\/feds-launch-cannabis-testing-program-to-help-consumers-know-what-theyre-buying\/\" target=\"_blank\" rel=\"noopener\">announced The Cannabis Quality Assurance Program (CannaQAP) last summer<\/a>. The program\u2019s goal, NIST said at the time, was \u201cto help laboratories accurately measure key chemical compounds in marijuana, hemp and other cannabis products including oils, edibles, tinctures and balms.\u201d<\/p>\n<p>Laboratory testing of cannabis has been happening more or less openly in the U.S. for years, at least since the early days of medical marijuana dispensaries in California. While NIST has acknowledged that most existing product labels already included concentrations of at least THC and CBD, the agency says many labs don\u2019t have sufficient experience conducting those tests, which has led to \u201cunreliable\u201d results.<\/p>\n<p>NIST already guides standardized testing and measurement in other industries, such as dietary supplements and food safety. \u201cWe work already in this space with regulators, product manufacturers, farmers, on the forensic side as well as in other areas,\u201d&nbsp;NIST research chemist Brent Wilson told Marijuana Moment in a recent interview. \u201cWe had the interaction with them already, and we knew that they needed us to get involved to help improve the analytical testing [of cannabis] that\u2019s being done in the community.\u201d<\/p>\n<p>The first exercise in the CannaQAP program, which is the subject of the new <a href=\"https:\/\/www.nist.gov\/publications\/cannabis-quality-assurance-program-exercise-1-final-report\" target=\"_blank\" rel=\"noopener\">report<\/a> released last week, involved evaluating how laboratories determine the concentration of cannabinoids in hemp oils. Testing laboratories across the country were sent two samples of hemp oils containing known concentrations of THC, CBD and 15 other cannabinoids. After testing the samples, the labs returned their results to NIST along with an explanation of their testing methods.<\/p>\n<p>The primary goal of the first&nbsp;report, published July 27, is meant to show how much variability exists between testing labs and methods. Its goal is to be observational and educational, not to pass judgment on the labs techniques or measurements. It published results in anonymized form, looking for how much measurements varied. \u201cThere needs to be a platform for these laboratories to demonstrate their confidence without worrying about\u2026failing or passing a test that they\u2019re taking part in,\u201d Wilson said.<\/p>\n<p>Overall, 116 laboratories participated, although not all reported results for each sample, nor did all submit results for each cannabinoid contained in the samples they analyzed. According to a <a href=\"https:\/\/qa.nist.gov\/cannaqap\/index.php\" target=\"_blank\" rel=\"noopener\">list<\/a> of self-identified participants, the group comprised an international mix of commercial labs that already focus on cannabis testing, commercial or academic chemical testing labs, law enforcement agencies and assorted others. Overall, about 83 percent returned data to NIST, Wilson said.<\/p>\n<p>\u201cThe industry as a whole compared pretty well with the target values,\u201d he said of the overall THC and CBD results covered in the report. \u201cThe accuracy as a community was good.\u201d<\/p>\n<p>Because the quality assurance program is intended to be anonymous and nonjudgmental, Wilson declined to draw any significant critical conclusions about the significance of the variability between laboratories\u2019 results. Asked how the group\u2019s cannabis results compared to those of other regulated industries NIST works with, he said the report showed \u201cvery similar results to what we\u2019d expect in any of the similar programs that we\u2019ve done. There\u2019s always going to be a large amount of variability at first [but] as things progress, we expect to see that variability shrink.\u201d<\/p>\n<p>\u201cWe generally don\u2019t go into the details about the capabilities of an industry,\u201d he added, explaining that job is better left to the U.S. Department of Agriculture or state regulators. \u201cOur main goal is just to try to improve the measurement capabilities.\u201d<\/p>\n<div id=\"attachment_48410\" class=\"wp-caption alignnone\"><img decoding=\"async\" aria-describedby=\"caption-attachment-48410\" loading=\"lazy\" class=\"size-large wp-image-48410\" src=\"https:\/\/www.marijuanamoment.net\/wp-content\/uploads\/2021\/08\/Screen-Shot-2021-08-05-at-16.24.16-1024x676.png\" alt=\"NIST THC results showing variability among testing laboratories\" width=\"740\" height=\"489\"><\/p>\n<p id=\"caption-attachment-48410\" class=\"wp-caption-text\">Results of laboratories\u2019 testing for delta-9 THC in a hemp oil sample (via NIST)<\/p>\n<\/div>\n<p>Wilson did draw a few broad conclusions about the quality assurance results. For one, laboratories overall generally clustered around the intended measurement of the test samples when testing for THC. But some returned results that were significantly above or below the target value. By comparison, labs that returned test results for CBD also clustered around the accurate result, but those that missed the mark tended to fall below the intended value. Compared to THC, Wilson added, CBD results also showed \u201ca fairly wide range of variability.\u201d<\/p>\n<div id=\"attachment_48411\" class=\"wp-caption alignnone\"><img decoding=\"async\" aria-describedby=\"caption-attachment-48411\" loading=\"lazy\" class=\"size-large wp-image-48411\" src=\"https:\/\/www.marijuanamoment.net\/wp-content\/uploads\/2021\/08\/Screen-Shot-2021-08-05-at-16.31.40-1024x664.png\" alt=\"NIST CBD test results showing variability among labs\" width=\"740\" height=\"480\"><\/p>\n<p id=\"caption-attachment-48411\" class=\"wp-caption-text\">Results of laboratories\u2019 testing for CBD in a hemp oil sample (via NIST)<\/p>\n<\/div>\n<p>Wilson attributed the difference between the two patterns as likely resulting from differences in calibration when conducting testing, though he said other differences\u2014such as testing method or storage conditions prior to testing\u2014may also explain the results. \u201cThe variability is there across all analytes being measured,\u201d he said\u2014which is to be expected.<\/p>\n<p>\u201cEverybody wants a true value for something, but the truth is that the true value is unknown,\u201d Wilson emphasized. \u201cSomebody tells you the concentration is 0.3 percent\u2014that\u2019s the estimated value. They don\u2019t know what the true value is.\u201d<\/p>\n<p>Every testing method\u2014and every test itself\u2014has minor differences that affect the end result such that it\u2019s impossible to eliminate any margin of error. Test a sample four times, and even the best tests will return minutely different numbers each time, he said. \u201cThere\u2019s always some type of uncertainty associated with that.\u201d<\/p>\n<p>One obstacle NIST faces in interpreting some of the results, Wilson said, is that in some cases a vast majority of labs, up to 93 percent, said they used similar testing methods for some compounds.<\/p>\n<p>\u201cThey used very similar types of methods,\u201d he observed, making it harder to identify how differences in testing method might influence results. \u201cIt makes it more difficult to understand if it\u2019s the method.\u201d<\/p>\n<p>NIST plans to conduct a similar test again in about a year to see how results compare to the first round of quality assurance testing. \u201cLet\u2019s test you and see how you do on the exact same matrix,\u201d Wilson explained. \u201cHave you improved your measurement capabilities from a year ago? \u2026 Part of the goal is just getting labs thinking about this and seeing what they can improve moving forward.\u201d<\/p>\n<p>The second of CannaQAP\u2019s exercises, which is still being prepared for publication, will focus on cannabis plant material and examine not only cannabinoids but also testing for moisture and toxic contaminants such as heavy metals. Exercise three has yet to be announced, but Wilson said he expected more information to be announced later this month. \u201cWe do have some things that we\u2019re planning to include, but I can\u2019t really divulge that right now.\u201d<\/p>\n<p>As part of its overall cannabis testing program, NIST is also working to develop a hemp reference material with known concentrations of various compounds, which the agency says labs could use to validate their testing methods. Currently no such cannabis reference material exists.<\/p>\n<p>A key motivation for the program as a whole was the 2018 Farm Bill, which legalized hemp across the country. Crucially, it defined hemp as cannabis that contains less than 0.3 percent THC\u2014an arbitrary distinction that sent law enforcement agencies and product manufacturers alike scrambling to test samples for compliance. \u201cLabs can have a hard time distinguishing between the two because accurately measuring THC can be difficult, especially at such low levels,\u201d NIST said in a January release.<\/p>\n<p>\u201cIf you\u2019re going to confiscate a farmer\u2019s crop, or subject a person to prosecution,\u201d Wilson said in a statement at the time, \u201cyou want to be sure that measurement is accurate.\u201d<\/p>\n<p>Exercise two of the quality-assurance program focuses on plant matter rather than homogenized oil, and it includes marijuana samples that exceed the 0.3 percent limit on THC in hemp. Participating laboratories\u2014220 signed up\u2014received six total samples, three of which were at or below the federal 0.3 percent cutoff, and three samples Wilson said were \u201caround 0.3 to 2 percent\u201d THC.<\/p>\n<p>Testing a Schedule I controlled substance\u2014any cannabis samples over 0.3 percent THC\u2014\u201dpresents additional challenges on our part,\u201d the researcher noted. For example, rather than simply shipping hemp samples, NIST has to ensure participating labs have the proper U.S. Drug Enforcement Administration paperwork so NIST can perform a legal transfer of marijuana.<\/p>\n<p>As the program evolves, Wilson said NIST expects to use samples that have higher concentrations of THC \u201cso we can target both hemp and marijuana companies that are out there to try to improve their capabilities.\u201d He also said future studies will focus on the wide array of products that cannabinoids are added to, including edibles, topicals and a range of nutritional supplements.<\/p>\n<p>\u201cThe entire cannabis space is still new in terms of testing,\u201d Wilson said. One thing he\u2019s heartened by is the broad consensus he says he\u2019s seen among researchers, law enforcement and commercial testing labs on the need for improved accuracy and standardization in testing. \u201cAcross all aspects of the community, all of them want to improve,\u201d he said. \u201cThe only path forward is together.\u201d<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"l9ydhzYNWd\">\n<p><a href=\"https:\/\/www.marijuanamoment.net\/new-marijuana-and-cbd-research-amendment-could-be-added-to-senates-infrastructure-bill-this-week\/\">New Marijuana And CBD Research Amendment Could Be Added To Senate\u2019s Infrastructure Bill This Week<\/a><\/p>\n<\/blockquote>\n<div class=\"cb_p6_patreon_button\">\n<p>Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.<\/p>\n<p><a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.patreon.com\/marijuanamoment?utm_content=post_button&amp;utm_medium=patron_button_and_widgets_plugin&amp;utm_campaign=749657&amp;utm_term=&amp;utm_source=https:\/\/www.marijuanamoment.net\/federal-science-agency-issues-first-report-on-thc-and-cbd-variability-in-cannabis-laboratory-testing-results\/\"><img decoding=\"async\" src=\"https:\/\/www.marijuanamoment.net\/wp-content\/plugins\/patron-button-and-widgets-by-codebard\/images\/become_a_patron_button.png\"><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>A federal science agency has released a new report as part of its effort to ensure that cannabis products are accurately tested and labeled for THC, CBD and more than a dozen other cannabinoids. It\u2019s part of an ongoing effort by the National Institute of Standards and Technology (NIST) to encourage standardized analysis of a wide range of cannabis compounds and contaminants across an ever-expanding class of legal products. The agency, part of the U.S. Department of Commerce, announced The Cannabis Quality Assurance Program (CannaQAP) last summer. The program\u2019s goal, NIST said at the time, was \u201cto help laboratories accurately&#8230; <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-961","post","type-post","status-publish","format-standard","hentry","category-connecticut-cbd-news"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/thcinct.com\/index.php?rest_route=\/wp\/v2\/posts\/961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thcinct.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thcinct.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thcinct.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thcinct.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=961"}],"version-history":[{"count":0,"href":"https:\/\/thcinct.com\/index.php?rest_route=\/wp\/v2\/posts\/961\/revisions"}],"wp:attachment":[{"href":"https:\/\/thcinct.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thcinct.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thcinct.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}